Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lein

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Urologic Oncology|April 6, 2010
Outcome prediction for prostate cancer detection rate with artificial neural network (ANN) in daily routineThorsten H Ecke, Peter Bartel, Steffen Hallmann, et al.
BMC Cancer|June 28, 2008
ADAM9 is highly expressed in renal cell cancer and is associated with tumour progressionFlorian R Fritzsche, Kirsten Wassermann, Monika Jung, et al.
International Journal of Cancer|August 14, 2009
Diagnostic and prognostic implications of microRNA profiling in prostate carcinomaAnnika Schaefer, Monika Jung, Hans-Joachim Mollenkopf, et al.
Anticancer Research|August 5, 2003
mRNA expression profile of matrix metalloproteinases and their tissue inhibitors in malignant and non-malignant prostatic tissueRalf Lichtinghagen, Petra B Musholt, Carsten Stephan, et al.
Clinical Chemistry|July 27, 2002
Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsiesCarsten Stephan, Henning Cammann, Axel Semjonow, et al.
European Journal of Medicinal Chemistry|April 23, 2015
Synthesis, crystal structure and effect of indeno[1,2-b]indole derivatives on prostate cancer in vitro. Potential effect against MMP-9Gricela Lobo, Melina Monasterios, Juan Rodrigues, et al.
European Urology|October 4, 2002
Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissueRalf Lichtinghagen, Petra B Musholt, Michael Lein, et al.
The Journal of Nutrition|July 28, 2005
Lycopene effects on rat normal prostate and prostate tumor tissueUlrich Siler, Angelika Herzog, Volker Spitzer, et al.
The Journal of Urology|November 11, 2005
A multicenter clinical trial on the use of (-5, -7) pro prostate specific antigenMichael Lein, Axel Semjonow, Markus Graefen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2010
Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohortRaquel Esgueva, Sven Perner, Christopher J LaFargue, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Urologic Oncology|April 6, 2010
Outcome prediction for prostate cancer detection rate with artificial neural network (ANN) in daily routineThorsten H Ecke, Peter Bartel, Steffen Hallmann, et al.
BMC Cancer|June 28, 2008
ADAM9 is highly expressed in renal cell cancer and is associated with tumour progressionFlorian R Fritzsche, Kirsten Wassermann, Monika Jung, et al.
International Journal of Cancer|August 14, 2009
Diagnostic and prognostic implications of microRNA profiling in prostate carcinomaAnnika Schaefer, Monika Jung, Hans-Joachim Mollenkopf, et al.
Anticancer Research|August 5, 2003
mRNA expression profile of matrix metalloproteinases and their tissue inhibitors in malignant and non-malignant prostatic tissueRalf Lichtinghagen, Petra B Musholt, Carsten Stephan, et al.
Clinical Chemistry|July 27, 2002
Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsiesCarsten Stephan, Henning Cammann, Axel Semjonow, et al.
European Journal of Medicinal Chemistry|April 23, 2015
Synthesis, crystal structure and effect of indeno[1,2-b]indole derivatives on prostate cancer in vitro. Potential effect against MMP-9Gricela Lobo, Melina Monasterios, Juan Rodrigues, et al.
European Urology|October 4, 2002
Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissueRalf Lichtinghagen, Petra B Musholt, Michael Lein, et al.
The Journal of Nutrition|July 28, 2005
Lycopene effects on rat normal prostate and prostate tumor tissueUlrich Siler, Angelika Herzog, Volker Spitzer, et al.
The Journal of Urology|November 11, 2005
A multicenter clinical trial on the use of (-5, -7) pro prostate specific antigenMichael Lein, Axel Semjonow, Markus Graefen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2010
Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohortRaquel Esgueva, Sven Perner, Christopher J LaFargue, et al.
Pageof 11